Valeritas Featured on Fox Business Network’s Top Morning Show

Fox Business Network's show "Mornings with Maria" featured firm client Valeritas Holdings, Inc. In the segment, Valeritas CEO John Timberlake discussed the V-Go daily insulin delivery device, which is the only such device worn as a patch, and is meant to make life easier for those with Type 2 diabetes. John Timberlake was joined by Joe …

Continue reading Valeritas Featured on Fox Business Network’s Top Morning Show

Harvard Stem Cell Institute Teaming Up to Develop Diabetes Cure

A group of Boston-area health institutions, known as the Boston Autologous Islet Replacement Program, are teaming up to develop, test and deploy stem cells to cure diabetes. The group includes the Harvard Stem Cell Institute, Brigham and Women's Hospital, the Joslin Diabetes Center, Dana-Farber Cancer Institute and Semma Therapeutics. The innovation began when Doug Melton, Co-Director …

Continue reading Harvard Stem Cell Institute Teaming Up to Develop Diabetes Cure

Interview with MBBP Client Valeritas Included in Wall Street Transcript Medical Devices Report

The most recent Wall Street Transcript Medical Devices Report includes an interview with Valeritas, Inc.'s CEO, John Timberlake.  Timberlake discusses in detail Valeritas's V-Go Disposable Insulin Delivery Device. The V-Go is a wearable basal-bolus insulin delivery device that allows patients to deliver insulin at a continuous preset basal rate, with bolus delivery as needed.  The V-Go …

Continue reading Interview with MBBP Client Valeritas Included in Wall Street Transcript Medical Devices Report

MBBP Client Valeritas Files IPO

On February 12, 2015, MBBP client Valeritas, Inc., a medical technology company focused on the development and commercialization of innovative drug delivery solutions, filed for a $90 million IPO. The filing with the SEC arrives one week after insulin pump maker Asante Solutions postponed its proposed $49 million offering. Valeritas markets a disposable device that …

Continue reading MBBP Client Valeritas Files IPO